|
| ID |
DDInter1609 |
| Drug Type |
small molecule |
| Molecular Formula |
C19H18Cln3O5S |
| Molecular Weight |
435.888
|
| Description |
Rivaroxaban is a factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations.
|
| ATC Classification |
B01AF01
|
| IUPAC Name |
5-Chloro-N-{[(5S)-2-Oxo-3-[4-(3-Oxomorpholin-4-Yl)Phenyl]-1,3-Oxazolidin-5-Yl]Methyl}Thiophene-2-Carboxamide |
| InChI |
Inchi=1S/C19H18Cln3O5S/C20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/H1-6,14H,7-11H2,(H,21,25)/T14-/M0/S1 |
| InChI Key |
KGFYHTZWPPHNLQ-AWEZNQCLSA-N |
| Canonical SMILES |
ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O |
| Useful Links |
DrugBank
ChEMBL
PubChem
|